AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...

The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.

While Watch Series 4 and its successors will undoubtedly bring this life-saving technology to millions of people over the next several years, Apple was not the first to bring it to market. That ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...

Smartphone-connected ECG maker AliveCor is teaming up with the Mayo Clinic once again, this time to develop algorithms to screen for Long QT syndrome, a heart condition that can often cause sudden ...

Mountain View, California-based AliveCor, which makes an FDA-cleared mobile electrocardiogram (ECG) device and companion app collectively called Kardia Mobile, has released new features that make it ...

Health technology company AliveCor, maker of connected electrocardiogram devices, is trying to ban U.S. sales of the Apple Watch, claiming the tech giant allegedly infringed on three of its patents.